Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Newly identified human natural killer cell-activating factor reported by HGS

Feb. 3, 1998

Pharmacological profile of new alkylating agent from Menarini

Feb. 3, 1998

Structure of new IL-6 inhibitors determined at Kitasato Institute

Feb. 2, 1998

Suramin submitted for FDA approval for cancer indication

Jan. 30, 1998

Phase I/II trial results reported for Neovastat in lung cancer

Jan. 30, 1998

Hybridon antitumor antisense compound enters clinical trials

Jan. 29, 1998

Pacific's cancer immunotherapy proves highly effective in rat metastatic mammary tumor model

Jan. 28, 1998

BMS discloses new Taxol derivative

Jan. 28, 1998

Flavopiridol analogues as inhibitors of cyclin-dependent kinases

Jan. 28, 1998

Antitumor and antiviral distamycin derivatives from Pharmacia & Upjohn

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...